Skip to content

The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG

The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03227393
Enrollment
0
Registered
2017-07-24
Start date
2017-09-30
Completion date
2017-10-27
Last updated
2018-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Systolic

Keywords

Heart Failure, Systolic, Defibrillators, Implantable, Pacemaker, Artificial

Brief summary

The purpose of this study is to evaluate if yoga practice will reduce cardiac sympathetic activity and subsequently cardiac arrhythmias.

Detailed description

Subjects with reduced ejection fraction will be randomized to 8 weeks Yoga training (1 in class session and home practice) vs. no Yoga. They will undergo holter monitoring, cardiac device interrogation, and I-123 mIBG imaging at the beginning and end of the study.

Interventions

BEHAVIORALYoga training

Subjects will complete in class yoga training weekly for 8 weeks with additional practice at home

Sponsors

University of Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Negative pregnancy test in females * Ejection Fraction \</= 40% assessed by echocardiogram within the last 12 months * Stable dose of heart failure medications including afterload reducing medication such as ACE-I, ARB and hydralazine; beta blockers; digoxin and aldosterone antagonist for at least 4 months and no anticipated changes for 8 weeks. (i.e. no greater than a 50% dose change within the past month) * Has an implantable pacemaker or ICD * NYHA II-IV

Exclusion criteria

* pregnant or lactating female * females without a pregnancy test * co-administration of a positive inotrope (i.e. milrinone or dobutamine) * history of significant medical non-compliance * unwilling to adhere to the protocol * Orthopedic limitation making yoga participation difficult * Underlying cardiac rhythm other than sinus rhythm * Recent history within 6 months prior to enrollment of unstable coronary artery disease (unstable angina, recent heart attack, recent revascularization, or decompensated heart failure) * implantation of a cardiac resynchronization therapy device in the past 3 months. * TIA, CVA, or major surgery in the past 3 months * iodine or adreview (123-MIBG) allergy

Design outcomes

Primary

MeasureTime frameDescription
Cardiac sympathetic activity following yoga training8 weeksA comparison of of the I-123 MIBG heart to mediastinal uptake ratio at baseline and completion of the yoga training.

Secondary

MeasureTime frameDescription
Relationship between I-123MIBG heart-to-mediastinal ratios and the total atrial and ventricular arrhythmia burden.8 weeksAssociation between heart to mediastinum ration and ventricular arrhythmia burden

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026